GTP-binding mutants of rab1 and rab2 are potent inhibitors of vesicular transport from the endoplasmic reticulum to the Golgi complex by unknown
GTP-Binding Mutants of Rabl and Rab2 are Potent Inhibitors of 
Vesicular Transport from the Endoplasmic Reticulum to the Golgi Complex 
Ellen J. T'tsdale*, Jeffrey R. Bourne**, Roya Khosravi-Far*, Channing J. Der* and W. E. Balch* 
*  Departments of Cell and Molecular Biology, The Scripps Research Institute, La Jolla, California 92037; and 
*  La Jolla Cancer Research Foundation, La Jolla, California 92037 
Abstract.  We have examined the role of ms-related 
rab proteins in transport from the ER to the Golgi 
complex in vivo using a vaccinia recombinant T7 
RNA polymerase virus to express site-directed rab 
mutants. These mutations are within highly conserved 
domains involved in guanine nucleotide binding and 
hydrolysis found in ras and all members of the ras su- 
perfamily. Substitutions in the GTP-binding domains 
of rabla and rablb (equivalent to the ras  17N and 116I 
mutants) resulted in proteins which were potent trans 
dominant inhibitors of vesicular stomatitis virus glyco- 
protein (VSV-G protein) transport between the ER and 
cis Golgi complex. Immunofluorescence analysis indi- 
cated that expression of rablbl:u prevented delivery 
of VSV-G protein to the Golgi stack, which resulted in 
VSV-G protein accumulation in pre-Golgi punctate 
structures. Mutants in guanine nucleotide exchange or 
hydrolysis of the rab2 protein were also strong trans 
dominant transport inhibitors. Analogous mutations in 
rab3a, rab5, rab6,  and H-ras did not inhibit processing 
of VSV-G to the complex, sialic acid containing form 
diagnostic of transport to the trans Golgi compart- 
ment. We suggest that at least three members of the 
rab family (rabla, rablb,  and rab2) use GTP hydrolysis 
to regulate components of the transport machinery in- 
volved in vesicle traffic between early compartments 
of the secretory pathway. 
M 
EMBERS of  the rab family of ms-related small GTP- 
binding  proteins are associated  with subcellular 
compartments in both the endocytic and exocytic 
pathways (reviewed in Balch,  1990; Goud and McCaffrey, 
1991). These proteins are likely to be key regulatory compo- 
nents of protein complexes catalyzing the fission and fusion 
of transport vesicles between distinct subcellular compart- 
ments. In support of their proposed function, the rab-related 
yeast GTP-binding  proteins  YPTI  and  SEC4  have  been 
shown to be required for transport between the ER and the 
Golgi  complex (reviewed in Hicke and Schekman, 1990; 
Schmitt et al., 1988; Segev et al., 1988; Bacon et al., 1989; 
Baker et al., 1990; Kaiser and Schekman, 1990), and from 
the Golgi complex to the cell surface (Salminen and Novick, 
1987; Goud et al.,  1988; Walworth et al.,  1989), respec- 
tively. In addition, in vitro assays which efficiently reconsti- 
tute ER to Golgi ~kers  et al., 1987) and intra-Golgi trans- 
port (reviewed in Waters et al.,  1991; Rothman and Orci, 
1992) are sensitive to the nonhydrolyzable analog of GTP, 
GTP3,S (Melancon et al., 1987; Beckers and Balch,  1989). 
Within the mammalian rab gene family, rabla and rablb 
share 70-80% identity to YPT1 (Valencia et al., 1991). In 
fact, mouse rabla can complement mutant yeast which lack 
YPT1 (Haubruck et al., 1989). Although genetic studies in 
yeast have shown that the YPT1 gene is required in vesicular 
transport, there is limited data which demonstrates a similar 
role of the mammalian rabl homologue in membrane traffic. 
We have shown that a peptide homologous to the putative 
effector domain of the rabl  protein inhibits  ER to Golgi 
transport,  presumably by competition for a  downstream 
effector molecule(s) required for vesicle fusion (Plutner et 
al., 1990). In addition, a neutralizing monoclonal antibody 
specific for the rablb protein inhibits transport from the ER 
to the Golgi complex in vitro (Plutner et al.,  1991). 
All members of the ras superfamily contain highly con- 
served domains required for guanine nucleotide binding, 
GTP/GDP  1 exchange, and GTP hydrolysis (Bourne et al., 
1990;  Bourne et al.,  1991). These domains interact with 
proteins  which stimulate  guanine nucleotide dissociation 
(GDS), inhibit GDP exchange (GDI), and promote GTP hy- 
drolysis  (GAP)  (reviewed  in  Hall,  1990; Haubruck and 
McCormick, 1991; Wittinghofer and Pai, 1991; Takai et al., 
1992). A host of  amino acid substitutions (>100) made in the 
ras  GTP-binding  and  effector domains  have  led  to  the 
identification of several activation and inhibitory mutations 
(Barbacid,  1987). Similar substitutions  in the SEC4  and 
YPT1 proteins result in trans dominant negative phenotypes 
1. Abbreviations used in this paper: GAP, GTPase activating protein; GDI, 
guanine nucleotide dissociation inhibitor; GDS, guanine nucleotide dissoci- 
ation stimulator; NGS, normal goat serum; VSG-V, vesicular stornatitis vi- 
rus glycoprotein. 
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Becker et al.,  1991). 
Using  the  mutational analysis performed  on  ras  as  a 
model, we have explored the role of rab proteins in ER to 
Golgi complex transport  in mammalian cells  using  site- 
directed mutagenesis and a vaccinia based transient expres- 
sion system. We report that rabla and rablb mutants with al- 
tered GDP/GTP binding properties behave as potent trans 
dominant inhibitors of ER to Golgi complex transport in 
vivo. In addition, we provide evidence that mutations in the 
GTP-binding domains of rab2, a small GTP-binding protein 
localized to a post-ER, pre-Golgi intermediate compartment 
(Chavrier et al.,  1990a),  results in proteins which act as 
trans dominant inhibitors in vesicular traffic. Our results 
suggest that at least three members of the rab family (rabla, 
lb, and 2) are critical for regulating the biochemical ma- 
chinery involved in vesicle fission and fusion between early 
compartments of the secretory pathway. 
Materials and Methods 
Cell Culture and Generation of  Mutant Constructs 
HeLa cells were cultured in DME (Gibco BRL, Grand Island, NY) sup- 
plemented with 10% FBS and penicillin-streptomycin  in a 5% humidified 
CO2  incubator.  Rab expression constructs were generated from canine 
rabla (Chavrier et al., 1990a), rat rablb (Touchot et al., 1987), and human 
rab2, rab3a, tab5, and rab6 (Zahraoui et al.,  1989) eDNA sequences that 
have been generously provided by M.  Zerial (EMBL,  Heidelberg,  Ger- 
many) and A. Tavitian (INSERM, Paris,  France). All tab sequences were 
introduced into the Ndel and BamH1 sites of the pET3a vector (Novagen, 
Madison, WI) for expression (Studier et ai., 1990) from the T7 promoter 
as described previously  (Khosravi-Far et al., 1991). To generate structural 
mutants of each tab protein (see Table 2), oligonucleotide-directed  muta- 
genesis was done on M13 mpl8 vector constructs of each rab eDNA se- 
quence using the Polymerase HI Mutator protocol (Stratagene Corp., La 
Jolla, CA) or by Taql polymerase chain reaction DNA amplification.  All 
mutated tab sequences were verified by dideoxy  sequencing.  The pET-tab 
constructs were introduced into E. coli strain BL21-DE3 (Novngen) for ex- 
pression of recombinant tab protein and used for transfection experiments. 
The pAR-G (pET3a) plasmids encoding VSV-G and tsO45 VSV-G were ob- 
tained from J. Rose (Yale University, New Haven, CT) and C. Machamer 
(Johns Hopkins University,  Baltimore, MD). 
Transfection Procedure 
HeLa cells were plated (5  x  105/35 mm dish) on the day before transfec- 
tion. The cells were first washed two times with DME, then infected with 
a vaccinia T7 RNA polymerase recombinant virus (vTF7-3) (Fuerst et al., 
1986), at a multiplicity of 10 PFU/cell for 30 win with intermittent rocking 
in a 37~  incubator. The inoculum was removed and the cells cotransfected 
with 5 #g pET-tab plasmid DNA encoding for a mutated rab protein as de- 
scribed above, and 5 #g of plasmid encoding for VSV-G protein OAR-G) 
that had been premixed for 15 rain at room temperature in 1 ml DME and 
15/tl of the transfection reagent (TransfectACE  [Gibco-BRL])  as outlined 
by Rose  (Rose  et al.,  1991). 3 h  post-transfection,  an equal volume of 
DME/10% FBS was added to the cells and incubated for an additional 3 h 
to allow synthesis of VSV-G protein and the mutant tab protein. After the 
transfection  period, the media was removed and the cells incubated for 15 
win in methionine free MEM (Gibeo-BRL), biosynthetically labeled for 10 
win with 20/zCi tmns [35S]-labe1  (spec. act. 1192  Ci/mmol, ICN Biomedi- 
cals, Inc., Irvine, CA), then chased for 1 h in DME/10% FBS. The chase 
was terminated by the addition of  lysis buffer (50 mM Tris, pH 8.0, 150 mid 
NaCI,  1% Triton X-100, 1 mM PMSF) (Sigma Chemical Co., St.  Louis, 
MO) and the lysate precleared for 30 min. with 50 ~1 Pansorbin (Calbio- 
chem Corp., San Diego, CA). The soluble fraction was incubated overnight 
at 4~  with a monoclonal antibody to VSV-G (clone 8G5) and pansorbin. 
Immune precipitates were washed three times with 10 mM Tris, pH 6.8/1% 
SDS, befled, then centrifuged.  To the supernatant was added 30 ~1 of  0.2 M 
citrate, pH 5.5 and 5/~1  of endoglycosidase  H (endo H) (1 U/ml, Bovhringer 
Mannhelm Corp., Indianapolis,  IN) and the sample digested  overnight at 
370C. Samples  were analyzed by SDS-PAGE on 6.75% gels according to 
the method ofLaenunli (Laemmli, 1970). The gel was soaked in 1 M salicy- 
late/30% methanol for 30 rain, dried, then exposed to XAR-5 film (Eastman 
Kodak Corp., Rochester, NY) at -80~  Qnantitation  of the VSV-G protein 
was accomplished using densitometxy as described previously  (Beckers et 
al.,  1987; Beckers and Balch, 1989;  Schwaninger et ai.,  1991). 
Transport Kinetics and Protein Expression of rablbu~1 
HeLa ceils (3 x  106/10 cm dish) were infected/transfected  at a multiplicity 
of 10 PFU/Cell and 30/~g of mutant rab and 30 #g pAR-G, as described 
above. 2 h post-transfection,  the media was removed and saved, and the cells 
detached from the culture dish with PBS/50 mM EDTA.  The cells were 
washed one time with DME then replated at equal number in 35-ram dishes 
with transfection media  from  the  parental  dish  and  equal  volume  of 
DME/10% FBS. This would allow a common pool of transfected  cells to 
be analyzed.  At 3, 4, 5 and 6 h post-transfection  cells were biosynthetically 
labeled for 10 win and chased for 60 win in complete media, as outlined 
above. 
To determine the level of expression of the rub protein, a comparable 
number of cells at each time point were detached from the dish with 
PBS/EDTA and washed one time with 10/18 (10 mM KOAc/18 mM HEPES 
[pH 7.2]). The cells were resnspended in 10/18 containing protease inhibi- 
tots  (10 #g/ml leupeptin,  10 #l/ml aprotinin,  10 #M TLCK,  1 #g/wi 
chymotrypsin,  0.1  t~M  pepstatin),  swollen  on  ice  for  10  win.,  then 
homogenized by 10 passes through a 23 gauge needle after which the con- 
centration was adjusted to 25 mM KOAc/125 mM Hepes.  The nuclei were 
removed by centrifugation for 5 rain. at 3,000 RPM and the post-nuclear 
supernatant centrifuged at 30 PSI for 30 rain. at 4~  in a Beckman Airfoge. 
The supernatant was removed  and the membrane pellet resuspended in 
25/125. Protein determinations were made by the Micro BCA Protein Assay 
Reagent (Pierce Chem. Co., Rockford, IL). Aliquots of the supernatant and 
membrane fractions (100 #g total protein) were separated by SDS-PAGE 
on a  12% gel and transferred to nitrocellulose  (Schleicher and Schuell, 
Keene, NH) in 25 mM Tris pH 8.3, 192 mM glycine, 20% methanol. The 
membrane was blocked in  5  % nonfat  dry milk,  0.05  % Tween-20 in  TBS. 
Detection  of  rablb  was with the polyclonal  antibody  p68 (Plutner  et  al., 
1991)  followed  by I/~Ci  1251  Protein  A (spec.  act  85.6  t~Ci//zg,  ICN). Stan- 
dard curve  was generated  from purified  recombinant rab protein. 
Western Analysis of V~ld Type and 
Mutant Rab Proteins 
HeLa cells (5  x  105/35 mm dish) were infected/transfected,  as outlined 
above. 6 h post-transfection,  the cells were detached from the culture dish 
with PBS/EDTA,  washed two times with PBS, then tysed in 10% ~.A for 
2 h on ice. "ICA-precipitated material from the cells was washed one time 
with acetone and dissolved  in 100 ~1 of sample buffer (0.1% SDS, 0.5 M 
Tris-HCI,  pH 6.8, 10% glycerol,  5% B-mercaptoethanol,  and 0.1% brom- 
phenol blue). Samples were separated by SDS-PAGE using 12% gels and 
transferred to nitrocellulose as described above. After blocking, the mem- 
brane was incubated with the appropriate anti-rab antibody, washed then in- 
cubated with an alkaline phosphatase-conjugated  second antibody (Pierce 
Chemical Co.) and developed  with 5-bromo-4-chloro-3-indoyl  phosphate 
and nitroblue tetrazolium (Pierce Chemical Co.). HeLa cell (5  x  105) ly- 
sate of non-transfected cells was coanalyzed to determine the endogenous 
level of  rab protein. Purified recombinant  rab proteins were included as con- 
trols. Overexpression  of rab proteins was detected by antibody reagents 
specific for rablb (mSC6b) (Plutner et al., 1991), rab2 CW. E. Balch, unpub- 
lished data), tab5 (generously  provided by M. Zerial, EMBL) and a poly- 
clonal antibody which cross-reacts with rabla, lb, 3 and 6. 
Indirect Immunofluorescence 
Hela cells (5  x  105) were plated on coverslips  in 35-mm tissue culture 
dishes on the day before transfection.  Cells were infected/co-transfected 
as above with 5/~g pAR tsO45-G,  5/~g pET rablb and/or 5/~g of pET 
rablbulb Cells were incubated at 40~  for 4 h followed by incubation at 
32~  for 2 h. To terminate transport, the cells were transferred to ice, fixed 
in 2 % paraformaldehyde/PBS  for 10 rain at room temperature. Fixation was 
quenched with 10 mM ammonium chloride in PBS for 10 win then blocked 
in PBS/5 % normal goat serum (NGS) for 10 rain at room temperature. To 
detect intracellular VSV-G, cells were permeabilized with 0.05 % saponin 
in PBS/NGS for 10 win, washed with PBS, then incubated for 30 win with 
a  monoclonal antibody specific  for the VSV-G protein cytoplasmic tail 
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a-mouse antibody (Molecular  Probes, Inc., Eugene, OR) and 10/~g/ml 
FITC-conjugated  Lens culinaris lectin  (E-Y Laboratories,  San Mateo, CA) 
in PBS/NGS  to label  Golgi  compartments  containing  terminal  N-acetylglu- 
cosamine. For cell surface labeling, VSV-G  was detected  by an antibody 
specific for the extra-cellular  domain  of VSV-G (clone  8AG) followed  by a 
Texas red secondary  reagent, as described  above.  Coverslips  were  mounted 
in Moviol  (Calbiochem  Corp., San Diego, CA) and viewed  under a Zeiss 
Axiovert  fluorescence  microscope. 
Results 
A  Transient Expression System to Study rab Protein 
Function In lqvo 
To study the in vivo consequences of mutated forms of the 
rub proteins on vesicular traffic, we employed a transient ex- 
pression system in which HeLa cells are first infected with 
vaccinia T7 RNA polymerase recombinant virus (vTF7-3) 
then cotransfected with a  mutant rab plasmid DNA and a 
plasmid encoding for vesicular stomatitis virus glycoprotein 
(VSV-G)  (pAR-G)  which  serves as  the reporter molecule 
(Fuerst et al.,  1986; Moss,  1989). VSV-G protein is a type 
I  integral membrane protein which acquires two N-linked 
oligosaccharides  during  cotranslational  insertion  into  the 
ER.  Transport of VSV-G protein from the ER to the cis/ 
medial Golgi compartments results in processing of the high 
mannose  (mang)  endoglycosidase  H  sensitive  (endo  Hs) 
oligosaccharides found in the ER to the complex, endo H 
resistant (endo HR) forms present in the Golgi stack and on 
the plasma membrane due to trimming by Golgi associated 
mannosidases and glycosyl transferases. Appearance of the 
various  oligosaccharide  processing  intermediates  can  be 
used  to  follow the  transport  of VSV-G  through  the  cis, 
medial, and trans Golgi compartments. These intermediate 
forms of VSV-G can be distinguished by their unique mobili- 
ties after SDS-PAGE (Schwaninger et al.,  1991). 
To establish conditions to study transport, Hela cells in- 
fected with vTF7-3 were transfected with the VSV-G protein 
encoding plasmid at 60 min intervals, biosynthetically radio- 
labeled for 10 min, then chased for 1 h in the absence of  radio- 
label. Immunoprecipitated G protein was first detected 3 h 
post-transfection and continued to increase in concentration 
in a linear fashion with time (data not shown). We selected 
the 4-6 h post-transfection period to study transport because 
both rab and VSV-G proteins were expressed at significant 
levels without adversely affecting the secretory pathway. The 
rate of  transport of VSV-G from the ER to the Golgi complex 
in vaccinia infected cells transfected with the VSV-G plasmid 
after 5 h post-transfection is shown in Fig.  1. For each time 
point, immunoprecipitated VSV-G protein was digested with 
endo H, then analyzed by SDS-PAGE and fluorography to 
determine the extent of VSV-G processing from the endo 
Hs to the endo HR form. As  shown in Fig.  1, the appear- 
ance of the endo HR form of VSV-G, coincident with trans- 
port to the cis/mediai Golgi compartments, occurred with a 
half time of ,~ 30 min.  VSV-G protein was  quantitatively 
(90%)  converted to the endo HR form after a  60-75  min 
chase period (Fig. 1). The efficiency of transport in different 
experiments was found to vary from 70-90%. The kinetics 
of VSV-G transport were identical to those observed in the 
presence of rifampicin or hydroxyurea, reagents which in- 
hibit maturation of vaccirtia particles (Vos and Stunnenberg, 
1988; Moss et al.,  1991). 
Figure 1. Kinetics of transport of VSV-G from the ER to the Golgi 
complex in vaccinia infected/transfected HeLa cells. Vaccinia in- 
fection and pAR-G (a plasmid encoding the VSV-G protein) trans- 
fection were performed as described in Materials and Methods. 6 h 
post-transfection, cells  were biosynthetically labeled with trans 
(35S) for 10 min, then chased for the indicated time in radioactive 
free media. VSV-G  protein was immunoprecipitated and incubated 
in the absence (-) or presence (+) of endoglycosidase H (endo H) 
as described in Materials and Methods. The endoglycosidase sensi- 
tive (endo Hs, lower band) forms and endoglycosidase H resistant 
(endo Ha, upper band) form were separated by SDS-PAGE. The 
fraction (%) of VSV-G protein transported to the endo H resistant 
form (lower panel) was quantitated as described in Materials and 
Methods. VSV-G  protein is converted to the endo HR form with a 
half-time of 30 min. 
Mutations in GTP-Binding Domains of rub1 are Trans 
Dominant Inhibitors of  ER to Golgi Transport 
To identify rub proteins essential for vesicular transport be- 
tween the ER and the Golgi complex, we performed site- 
directed mutagenesis  within domains involved in guanine 
nucleotide interactions.  Ras and rab proteins contain four 
highly  conserved  GTP-binding  domains  (Bourne  et  al., 
1991; Valencia et al., 1991). Mutational and structural anal- 
ysis of the ras protein have determined essential amino acid 
residues in these domains for binding and hydrolysis of GTP 
(reviewed in Barbacid, 1987; Valencia et al., 1991) (Table 1). 
Amino  acid  substitutions  at  specific sites  in  the  guanine 
nucleotide binding domains of ras alter guanine nucleotide 
binding affinity for GDP and GTP (Table 2,  17 S-*A,  116 
Tisdale et al. Rabl and Rab2 Regulation of ER to Golgi Transport  751 Table 1. Comparison of  Regions of  Ras-related rab Proteins Involved in GTP-binding 
and Regulation of  GTP Hydrolysis 
H-Fas 
SEC4 
YPT1 
rabla(rat) 
rab  1  b(rat) 
rab2 
rab3 
rab5 
rab6 
10  30  57  113  187 
NH2--GAGGVGKS ....  DEYDPTIEDSYRKQV  .....  DTAGQEE ....  LVGNKCDL ....  CVLS-COOH 
-GDSGVGKS  ....  PSFITTIGIDFKIKT  .....  DTAGQER  ....  LVGNKSDM  ....  CC 
-GNSGVGKS  ....  NDYISTIGVDFKIKT  .....  DTAGQER  ....  LVGNKCDL  ....  CC 
-GDSGVGKS  ....  ESYISTIGVDFKIRT  .....  DTAGQER  ....  LVGNKCDL  ....  CC 
-GDSGVGKS  ....  ESYISTIGVDFKIRT  .....  DTAGQER  ....  LVGNKSDL  ....  CC 
-GDTSGVKS  ....  PVHDLTMGVEFGARM  .....  DTAGQER  ....  LIGNKSDL  ....  CC 
-GNSSGVKS  ....  PAFVSTVGIDFKVKT  .....  DTAGQER  ....  LVGNKCDL  ....  CAC 
-GESAVGKS  ....  EFQESTIGAAFLTQT  .....  DTAGQER  ....  LSGNKADL  ....  CCSN 
-GEQSVGKS  ....  NTYQATIGIDFLSKT  .....  DTAGQER  ....  LVGNKTDL  ....  CSC 
Phospho~l-  Eff~tor domain  Phospho~l-  Guanine  ring  P~nyl~ion 
bi~ing si~  binding site  contact  site  si~ 
* The amino  acid sequences  of rab-related  proteins  which make  up the functional  GTP-binding  and effector  domains  are compared  to H-ras (human). The number- 
ing is that of H-rus. The functional  designations  are based on the crystal structure of ras. Mutations  used in this study which alter GTP-binding  or hydrolysis 
for ras are indicated  by the asterisk although essentially  mutations at all positions  in these domains alter GTP-binding  or hydrolysis  (see Valencia  et al., 1991 
for review). 
N~I) (Der et al., 1988; Feig and Cooper, 1988), abolish in- 
teraction with GTPase activating protein (GAP) (Table 2, 35 
T~A) (Haubruck and McCormick,  1991) and impair GTP 
hydrolytic activity (Table 1,  12 G-'S, 61 Q~L)  (Haubruck 
and McCormick,  1991).  The prominent effects of these mu- 
tations on ras  biological function  and the conservation of 
these domains among all ras related proteins (Bourne et ai., 
1991;  Valencia et al.,  1991),  suggest that these regions are 
likely to contain key residues critical for rab function. 
To  study  the  in vivo effect of overexpression of mutant 
forms of rab proteins on vesicular transport, vTF7-3 infected 
HeLa cells were  cotransfected with  a  rat) mutant  and the 
VSV-G expression constructs for 5-6 h, pulse-labeled for 10 
min, then chased for 1 h  in nonradioactive medium to pro- 
mote transport to the Golgi complex. The first mutation we 
generated in rablb and rabla was a  substitution of N  to I at 
position  121.  The  main  function  of this highly conserved 
ASN is to hold together the three elements which are in- 
volved in guanine nucleotide binding. In the case of ras, mu- 
tations  in  the  consensus  guanine  nucleotide  binding  se- 
quence NKXD (Table 1, ras residues 116-119) have reduced 
guanine nucleotide binding affinity. As a consequence of en- 
hanced GDP/GTP exchange, rash61 is a  constitutively acti- 
vated, transforming protein.  The N  to I  substitution in the 
corresponding NKXD motif of both YPT1  and SEC4 result 
in  mutant  proteins  which  do  not bind  GTP  and  produce 
dominant lethal phenotypes and secretory defects when ex- 
pressed in yeast (Schmitt et al., 1986; Schmitt et al., 1988; 
Walworth et al.,  1989). 
As shown in Fig. 2, overexpression of rablbn. (~10-fold) 
Table II. Summary and Properties of  Rab Mutant Proteins 
Inhibition 
of ER-Golgi 
Mutant  Substitution*  Ras  ~  transport 
rablb22N  Ser(TCA)  - Asn(AAC)  17N  + 
rablb4oA  Thr(ACC)  - AIa(_GCC)  35A  - 
rablb41M  He(AT_T) - Met(ATG)  36M  -/+ 
rablb,N  Asp(GAC) - Asn(AAC)  39N  - 
rablb67L  GIn(CAG)  - Leu(CTG)  61L  - 
rablb1211  Asn(AA_C)  - He(A_T_C)  116I  + 
rablbmi,ACC  Asn(AA_C)  - Ile(ATC),  116I/ 
Cys(TGC_) - ter(TGA)  ACAAX  + 
rablbmx/rab5  Asn(AAC) - IIe(A_TC):  None 
tab  1  b(  1  - 150)/tab5( 163 -215) 
rablaml  Asn(AAC) - IIe(ATC)  116I  + 
rab220N  Ser(TCA)  - Asn(ACC)  17N  - 
rab23sA  Thr(ACT)  - AIa(GCT)  35A  - 
rab265L  GIn(CAA)  - Leu(CTA)  61L  + 
rab2ngl  Asn(AAT) - IIe(AT_T)  116I  + 
rab3at3sl  Asn(AA_C)  - Ile(ATC)  116I  - 
rab51331  Asn(AAC) - Ile(ATC)  116I  - 
ra61261  Asn(AAT) - IIe(A_TT)  116I  - 
H-rash61  Asn(AAC) - Ile(AT_C)  ll6I  - 
* Nucleotide substitutions  are underlined. 
t Analogous ras mutant protein. 
Figure  2. Mutations in GTP-binding domains of rabla and rablb are 
trans dominant inhibitors of transport from the ER to the Golgi 
complex.  Vaccinia  infection  and  cotransfection protocols  with 
pAR-G and mutant (pET) plasmids were as described in Materials 
and Methods. Briefly, 5 h post-transfection cells were labeled with 
trans (3~S) for 10 rain and chased for 60 rain in the absence of 
radiolabel. VSV-G protein was immunoprecipitated and digested in 
the absence (-) or presence (+) of endo H, and the endo H sensi- 
tive (S) or resistant (R~ and R2) forms analyzed by SDS-PAGE as 
described in Materials and Methods. R~ is a processing intermedi- 
ate with one of  the two oligosaccharide  chains processed to the endo 
H  resistant form  (Schwaninger et al.,  1991).  R2  is the form of 
VSV-G  containing two  endo  H  resistant oligosaccharides fully 
processed and containing sialic acid. Transport of VSV-G protein 
from the ER to the Golgi complex is totally inhibited in cells over- 
expressing rablbl21i, and rabla12tl, and rablb22s. 
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(Fig. 2,  lane l).  No processing of VSV-G protein to endo 
Ha forms was observed after the 60 min chase period com- 
pared to the control in which 75 % of the VSV-G protein was 
processed to the endo H  resistant form (Fig.  2,  compare 
lanes b and l). VSV-G neither accumulated in the Man5 en- 
doglycosidase D sensitive form (data not shown), a process- 
ing reaction diagnostic of protein transport to the cis Golgi 
compartment  in  the  mutant  CHO  cell  line  clone  15B 
(Beckers et al.,  1987),  nor in an early endo HR processing 
intermediate observed in the control (RI in Fig. 2, lanes b 
or d) diagnostic of transport from the ER to the cis Golgi 
compartment in wild-type CHO cells (Schwaninger et al., 
1991).  Identical results  were  obtained  for  rablam~  (95% 
identity with rablb)  (Fig.  2, lane j).  As expected, recom- 
binant rabla~2H (data not shown) or rablb~2~t did not bind de- 
tectable levels of GTP (<0.1%) compared to the wild-type 
proteins measured in solution or by Western blotting (Fig. 
3, lanes a and e). In contrast, VSV-G protein was efficiently 
(>85 %) transported and processed to the fully sialylated, 
complex form (R2 in Fig. 2, lane d) in the presence of over- 
expressed  (~10-fold)  wild-type rablb  or  wild-type rabla 
(data not shown). We have been unable to detect any statisti- 
cally significant change in the extent or rate of processing of 
VSV-G to endo Ha forms in cells overexpressing (10-fold) 
wild-type rabla or lb (data not shown), suggesting that the 
endogenous rabl protein is not rate limiting for transport of 
VSV-G protein from the ER to the terminal compartments 
of the Golgi complex. 
To provide evidence that expression of the rablbm~ pro- 
tein imposes a transport block between the ER and the Golgi 
stack, we analyzed the distribution of  VSV-G in the presence 
of rablb~2,  by indirect immunofluorescence. For this pur-' 
pose, Hela cells were transfected with a plasmid (pAR-tsO45-G 
protein) expressing a temperature-sensitive form of VSV-G 
which misfolds at the restrictive temperature (39.5~  and 
fails to be exported from the ER (Lafay, 1974; Balch et al., 
1986) (Fig. 4, A [VSV-G] and B [Golgi complex]). TsO45- 
VSV-G is rapidly mobilized to the Golgi membranes when 
shifted to  the permissive temperature  (32~  (Fig.  4,  C 
[VSV-G] and D [Golgi complex]). When cells cotransfected 
with pAR-tsO45-G and wild-type rablb and were held at the 
restrictive temperature for 4 h followed by a 90 min chase 
at the permissive temperature, VSV-G protein was found to 
be efficiently transported to the Golgi complex (Fig. 4, E, 
E' [VSV-G] and F, F' [Golgi complex]). In contrast, expres- 
sion of rablbmi resulted in the inability of VSV-G to enter 
the Golgi stack. The tsO45-G protein was partially trans- 
ported  to  punctate  structures  scattered  throughout  the 
cytoplasm (Fig. 4,  G, G' [VSV-G] and H, H' [Golgi com- 
plex]), similar to the distribution of pre-Golgi intermediates 
in BHK cells (Saraste, 1984;  Saraste et al., 1991). Further- 
more, cells expressing tsO45 VSV-G and rablb~2u failed to 
transport VSV-G protein to the surface (Fig. 5, B) indicative 
of a block in transport. 
The striking inhibition of protein transport produced by 
expression of rablb12H prompted us to examine the thresh- 
old of this  mutated protein  required  to  inhibit vesicular 
traffic. Cells cotransfected with the VSV-G protein encoding 
plasmid and pET rablb~2~, were radiolabeled at 3, 4, 5, and 
6 h post-transfection for 10 min, chased for 1 h, then trans- 
port assessed as described above. In addition, the level of ex- 
Figure 3.  [3,35I]]GTP-binding  to rabl and rab2 wild-type and mu- 
tant proteins after Western  blotting. Equivalent  mounts of  the indi- 
cated wild-type and mutant proteins were bacterially expressed and 
separated by SDS-PAGE, then transferred to nitrocellulose f~ters. 
The filters were then incubated with I/~M [y35S]GTP in 50 mM 
Tris, 0.3% Tween, 0.5 M EDTA, 0.5 M MgCI:  and 10 #M of cold 
GTP (Schmitt et al., 1986). The bound [35S]GTP was visualized 
by fluorography. 
pression and distribution of rablb between membrane and 
cytosol was quantitated by Western blotting (Fig. 6). The en- 
dogenous pool of rablb in Hela cells is distributed between 
membrane-associated and soluble forms (Fig. 6, B). Expres- 
sion of rablb12~ after a 3 h post-transfection period resulted 
in •2  fold increase in the total rab pool (Fig. 5, B). Even 
at this level of expression of the mutant protein, VSV-G pro- 
tein transport to the Golgi complex was reduced by *25 % 
(Fig. 5, A). From 4 to 6 h post-transfection, a 5- to 10-fold 
increase in rablbm~ was observed with rablbm, now being 
detected increasingly in the membrane fraction (Fig. 3, B). 
At 6 h post-transfection transport was inhibited >80% (Fig. 
5, A). In general, overexpression of rablbm~ in the range of 
four to eightfold results in the total arrest of VSV-G protein 
transport and processing to the endo Ha form as early as 
3-4 h post-transfection. We have been unable to reverse inhi- 
bition by cotransfection with pET wild-type rablb suggesting 
that the rablb12~ mutant irreversibly inhibits transport (data 
not shown). 
Tisdale et al. Rabl and Rab2 Regulation  of ER to Golgi  Transport  753 F/gum 4. Rablbm~ inhibits transport to the Golgi complex. Vaccinia infected cells (see Materials and Methods) were transfected with 
rablb or rablbmt cDNA, and a plasmid expressing the temperature-sensitive mutant form of VSV-G protein (pAR-tsO45-G) for 4 h at 
39.5"C to retain tsO45 VSV-G in the ER. 4 h post-transfection, cells were shifted to the permissive temperature (32~  and incubated 
for 2 h. Cells were fixed, permeabilized, and the distribution of tsO45 and VSV-G protein (A, C, E, E', G, G5 and Golgi membranes 
(B, D, F,, F', H, H') viewed by immunofluorescence microscopy as described in the Materials and Methods, (A, B) Distribution of tsO45 
VSV-G (A) or Golgi membranes (B) after 6 h continuous incubation at 39.5~  (C, D) Distribution of tsO45 VSV-G (C) or Golgi mem- 
branes (D) after incubation for 2 h at 320C. (E, F) Distribution of tsO45 VSV-G (E, E') or Golgi membranes (F,, F') after incubation 
for 2 h at 32"C in the presence of rablb protein. (G, H) Distribution of tsO45 VSV-G (G, G') or Golgi membranes (H, H') after incubation 
for 2 h at 32~  in the presence of rablbm~ protein. 
To further characterize the role of GTP-binding in the 
regulation of rabl function in ER to Golgi traffic, mutations 
were generated in two domains involved in either interaction 
with the phosphates or the guanine ring (Table 1). Rablb22N 
(Table 2) is equivalent to the raslTN mutation which exhibits 
a 20-fold reduced affinity for GTP but not GDP. It is thought 
that raslTN is locked in the GDP-bound form and to be as- 
sociated constitutively with a ras guanine nucleotide dissoci- 
ation stimulator (GDS) (Feig and Cooper, 1988). This mu- 
tant is a potent inhibitor of  mammalian cell proliferation and 
believed to antagonize normal ras function by competition 
for  GDS.  As  shown  in  Fig.  2  Oane f),  expression  of 
rablb22N ("ol0-fold)  above  the  endogenous  pool  of rablb 
(data not shown) potently inhibited transport resulting  in 
<2%  of VSV-G processed to the endo FIR forms. In con- 
trast,  overexpression of rablb67L (Table 2),  which  in  ras 
(ras61L) eliminates the intrinsic and GAP-stimulated GTPase 
activities (Haubruck and McCormick, 1991), did not inhibit 
transport (Fig.  2,  lane h,  85 %  endo HR) when expressed 
>10-fold over the endogenous wild type protein based on 
Western blotting (data not shown). The equivalent mutation 
in the SEC4p (SEC479L)  does not inhibit transport from the 
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of VSV-G transport  from the ER to the  Golgi complex.  Infec- 
tion/transfection  conditions and analyses were as described in the 
legend of Fig. 3, and in Materials and Methods.  (,4) Extent of inhi- 
bition of VSV-G protein transport by rablb~2u at 3, 4, 5,  or 6 h 
post-transfection.  (B) The level of expression  of mutant rablbl2u 
protein assessed  by Western  blotting after 3,  4,  5,  or 6  h post- 
infection/transfection.  Cytosolic fraction (C) and membrane frac- 
tion (M) were prepared as outlined in Materials and Methods.  The 
control lane (ctl) shows the level of endogenous rablb.  (C) The 
standard curve for rablb concentration was generated using puri- 
fied recombinant rablb. 
Figure 5. VSV-G protein is not delivered to the cell surface in HeLa 
cells expressing rablb12u. Vaccinia infected cells (see Materials  and 
Methods) were transfected  with a plasmid expressing  the tempera- 
ture-sensitive  mutant form of VSV-G protein (pAR-tsO45-G) in the 
absence (,4) or presence (B) of the plasmid expressing  rablbml for 
4 h at 39.50C. After 4 h, cells were shifted to the permissive tem- 
perature (32~  and incubated for 2 h. Cells were fixed and surface 
expression of tsO45  VSV-G protein determined  by indirect im- 
munofluoresccncr using an antibody specific  for the extracellular 
domain of VSV-G as described in Materials and Methods. 
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expected, rablb:2N did not bind GTP after Western blotting 
whereas rablb~TL  GTP-binding was normal (Fig, 3, compare 
lanes b and d). 
Rablbuu Lacking the Carboxyl-terminal CC Motif 
Is a Trans Dominant Inhibitor of Transport 
Prenylation of the carboxyl-terminal cysteine residues  of 
small  GTP-binding  proteins  is  required  for  membrane 
association and function (reviewed in Der and Cox,  1991) 
(Table  1).  We have previously demonstrated that the car- 
boxyl-terminal CC residues of rablb are post-translationally 
modified by a  geranylgeranyl isoprenoid (Khosravi-Far et 
al., 1991). To assess the importance of this modification in 
rablb function, truncation (ACC) mutants were generated 
from the wild-type rablb and mutant rablbm~ proteins. As 
shown in Fig. 7, deletion of the terminal CC residues from 
the wild-type protein had no effect on transport. VSV-G pro- 
tein was efficiently processed to the endo Ha form (Fig. 7, 
lane d, 65 % endo Ha). Rablb~cc bound GTP at levels com- 
parable to the wild-type protein (not shown). In contrast, 
and to our surprise, the rablb~2~],  ~cc mutant inhibited ER to 
Golgi transport  as efficiently as the nontruncated mutant 
(Fig.  6,  lane f,  <1%  endo  Ha)  suggesting  that  a  non- 
prenylated form of the mutant can effectively interfere with 
some  aspect  of the  transport  machinery  governing  rabl 
function. 
To  determine whether  additional sequence  information 
in the carboxyl-terminus of rablb was necessary to yield 
the trans dominant phenotype produced by the rablbmi mu- 
tant,  we replaced the COOH-terminal 35  amino acids of 
rablbt2, with the carboxyl-terminal 35 amino acids of rab5 
to  generate  the  hybrid  construct  rablb~Hs0)t2~drab5,6~-~89) 
(Table 2). The carboxyl-terminus of rab5 has been suggested 
to encode key information dictating the localization of the 
rab5 protein to an early endosome compartment (Chavrier 
et al., 1991). This mutant chimera binds GTP indicating that 
it folds properly to form a native structure (data not shown). 
In contrast to rablbm~, ~cc, overexpression (*10-fold) of the 
hybrid (data not shown) had no effect on VSV-G transport 
(Fig. 7). 
Rabl Effector Domain Mutations 
Mutations in amino acids 32-40 of ras (the effector domain 
[Table 1]) do not, for the most part, alter the intrinsic proper- 
ties of ras yet abolish transforming activity of the oncogenic 
forms (Hall, 1990; Haubruck and McCormick, 1991). Mu- 
tations in this region which destroy ras transforming activity 
typically eliminate the ability of GAP to bind efficiently to 
ras.  Although the ras and rab effector domains are highly 
divergent, the 35T residue within the ras effector domain is 
invariant among all ras  and ras-related proteins (Table  1) 
(Velencia et al., 1991; Wittinghofer  and Pai, 1991). Substitu- 
tion of 35T with A results in loss of ras transforming activity 
and prevents GAP stimulation of GTPase activity. 
To determine whether mutations in the rablb effector do- 
main would inhibit ER to Golgi transport, three different 
mutants were  generated (Table  2):  rablb40A, rablb4~M and 
rablb**s. In the case of rablb4~M GTP-binding is comparable 
to  the  wild-type protein  (Fig.  3,  lane  c).  Rablb4tM and 
rablb**N are identical to YPTIp effector domain mutants re- 
cently reported to yield secretory defects in ER to Golgi 
transport in yeast (Becket et al., 1991). As shown in Fig. 8, 
we have  detected weak,  yet reproducible  inhibition with 
rablb4~M (Fig.  8,  50%  endo Ha).  This mutation in YFEp 
yields the strongest trans dominant phenotype (Becker et al., 
1991). In contrast, no inhibition was observed by overexpres- 
sion of the rablb40^ or rablb~N (Fig.  8).  Because the 44N 
substitution  in  YPT1  results  in  a  temperature  sensitive- 
phenotype (Becker et al.,  1991) we tested whether a block 
in transport could be detected at an elevated temperature 
(39.5~  in the presence of the rablboN protein. As before, 
no inhibitory phenotype was detected (data not shown). In 
all cases, expression levels were ,,ol0-fold that of the endoge- 
nous pool (data not shown). These results are compatible 
with the observation that effector domain mutations in mam- 
marian ras are generally neither trans dominant nor growth 
inhibitory (Hall, 1990;  Haubruck and McCormick, 1991). 
Mutations in the GTP-Binding Domains of  rab2 are 
Trans Dominant Inhibitors of  ER to Golgi Transport 
The  tab2  protein,  which  is  highly divergent from rablb 
(<40% identity), has been immunolocalized to the tubular- 
vesicular compartments believed to function in ER to Golgi 
Figure 7.  The effect of carboxyl-terminal mutations in rablb on 
VSV-G protein transport from the ER to the Golgi complex. Infec- 
tion/transfecfion conditions and  analyse~s were as  described in 
Materials and Methods. Overexpression of the double mutant, 
rablB12u, ace, resulted in a complete inhibition of VSV-G transport. 
lqgure 8. Effect of VSV-G transport in ceils expressing mutations 
in the effector domain of rablb. Infection/transfection  conditions 
and analyses were as described in Materials and Methods. 
The Journal  of Cell Biology,  Volume 119, 1992  756 Figure 9. Evaluation of GTP-binding and effector domain mutants 
of  rab2 on ER to Golgi transport of VSV-G protein. Infection/trans- 
fection conditions and analyses were as described in Materials and 
Methods. 
transport (Chavrier et al.,  1990a).  However, no genetic or 
biochemical evidence is currently available which demon- 
strates its involvement in vesicular traffic. 
To determine if rab2 functions in ER to Golgi transport, 
rab2 mutants were generated based on our observations for 
the  rablb  constructs  (Table  2).  We  first  tested  rab2,9~ 
(equivalent to rablbm~), a mutant which was likely to yield 
a trans  dominant inhibitory phenotype.  Rab2Hg~ failed to 
bind GTP on Western blots (Fig. 3, lane j) and strongly in- 
hibited protein transport from the ER to the Golgi complex 
(Fig. 9, <5 % endo H resistant). In contrast, expression of 
rab2 wild-type protein neither stimulated nor inhibited the 
transport of VSV-G protein to the Golgi (Fig. 9, 65 % endo 
HR). Three additional mutants were generated (Table 2):  1) 
rab220N, analogous  to  the  rasl7N mutation,  2)  rab238A, an 
effector domain mutation, and 3) rab265L corresponding to 
the oncogenic ras61L mutation. We observed (Fig. 2, lane  f) 
only a  partial  inhibition in  membrane  traffic  by  rab220N 
(Fig.  9,  45%  endo  Ha),  although  it  was  expressed  as 
efficiently as rabl proteins (~10-fold) and did not bind GTP 
after Western blotting  (Fig.  3,  lane g).  Surprisingly, the 
rab265L mutant was a potent inhibitor of transport (Fig. 9, 
<1%  endo  Ha)  and bound GTP  at  levels comparable  to 
wild-type (Fig.  3,  lane i).  The equivalent rablb67L had no 
effect on transport (Fig. 2, lane h). We have also consistently 
detected a weak, but reproducible inhibitory phenotype with 
the rab238A effector domain mutation (Fig.  9,  40%  endo 
Ha).  As expected, GTP-binding by this mutant was com- 
parable to wild type (Fig. 3, lanes f  and h). The combined 
results suggest not only that rab2 is critical for ER to Golgi 
traffic,  but  the  biochemical  interactions facilitating rab2 
function differ from those for rablb. 
Overexpression of rab3a,  rab5, rab6 Wild Type 
and GTP-Binding NKXD Mutant Proteins Have No 
Effect on Vesicular Traffic Between the ER 
and the Golgi Complex 
To show that VSV-G protein transport inhibition between the 
ER and Golgi compartments is specific to those rab mutants 
described above, we expressed rab proteins which have been 
reported to participate in other steps of vesicular transport. 
To this end, we introduced the equivalent rasH~ mutation in 
rab3a, rab5, and rab6. Rab3 is involved in regulated exocyto- 
sis in endocrine, exocrine, and neural tissues and has been 
Figure I0. Substitution  of 116I (ras numbering) in the GTP-binding 
domains of rab3a, rab5, and ras does not inhibit VSV-G protein 
transport from the ER to the Golgi complex when expressed in Hela 
cells. Infection/transfection conditions and analyses were as de- 
scribed in Materials and Methods. 
localized to exocytic vesicles (Darchen et al.,  1990;  Fisher 
von Mollard et al.,  1990).  Rab5 has been localized to en- 
dosomal compartments and is involved in early endosome 
fusion in vitro (Chavrier et al.,  1991; Gorvel et al.,  1991). 
The rab6 protein has been localized to the medial-trans com- 
partments of the Golgi complex (Goud et al., 1990).  As in- 
dicated in Fig.  10, overexpression (•10-fold)  of the wild- 
type or mutant rab3a~3m wild-type or mutant rab5~3~, or 
H-rasH61 had no statistically significant inhibitory or stimu- 
latory effect on processing of VSV-G protein to the endo Ha 
form. In addition, we have been unable to detect any inhib- 
itory effect of overexpression of rab6~26~ on processing of 
VSV-G to the terminally sialylated, complex form (Fig. 11). 
Given that sialyltransferase is a late-processing enzyme pre- 
dominantly found in the trans Golgi compartment and trans 
Golgi network, these results suggest that rab6 is not essential 
for transport between cis,  medial or trans Golgi compart- 
ments. Similarly, the inability of H-ras, rab3a, rab5 and rab6 
NKXD mutant proteins to inhibit VSV-G transport between 
the ER and the Golgi complex indicates that these proteins 
do not interact with the biochemical machinery g~'erning 
rabl  or rab2 function. 
Discussion 
Disruption of  ER to Golgi Transport by rabl and rab2 
Mutations Affecting GTP Binding and Hydrolysis 
Mutational analysis of ras and ras-related proteins has re- 
Figure 11. Expression of rab6n~ does not inhibit VSV-G protein 
transport from the ER to the Golgi complex. Infection/transfection 
conditions and analyses were as in Materials and Methods. 
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in GTP binding, exchange and hydrolysis required for func- 
tion. We have used the structure/function data reported for 
the ras protein as our prototype to map functional domains 
in the rab proteins necessary for vesicular traffic from the ER 
to the Golgi complex. 
Since guanine nucleotide binding regulates the biological 
activity of ras, we generated the N to I substitution in the 
consensus NKXD (ras residues  116-119) GTP-binding do- 
main present in all ras-related proteins. While this substitu- 
tion activates ras transforming potential (Der et al.,  1988), 
analogous mutants of YPT1  (Schmitt et al.,  1986;  Schmitt 
et al., 1988),  SEC4 (Walworth et al., 1989), and rab5 (Gor- 
vel et al.,  1991) exhibit trans dominant inhibitory pheno- 
types. To identify trans dominant inhibitors of ER to Golgi 
transport we made use of the T7 RNA polymerase produced 
by recombinant vaccinia virus to direct high level transient 
expression of rab proteins and VSV-G protein. In this sys- 
tem,  rablb~2H was  a  potent  inhibitor  of VSV-G  protein 
transport from the ER to the Golgi complex based on the ob- 
servation that the two N-linked oligosaccharides of VSV-G 
protein failed to be processed to early post-ER,  cis Golgi 
forms (Schwaninger et al.,  1991). Indirect immunofluores- 
cence  studies  confirmed the biochemical  results:  VSV-G 
failed to enter the Golgi stack and was not detected on the 
cell surface. Thus,  it is unlikely that the inability to trim 
VSV-G protein oligosaccharides to endo Ha forms is due to 
a processing defect per se or an "end-run" around the Golgi 
complex. The punctate intermediates in which VSV-G accu- 
mulated in the presence of the rablbnH  mutant was strik- 
ingly similar to the distribution of  a putative pre-Golgi inter- 
mediate compartment postulated to be involved in ER to 
Golgi transport (Saraste and Kuismanen, 1984; Saraste and 
Svensson, 1991; Schweizer et al., 1988).  Although the data 
presented here does not directly  distinguish  between accumu- 
lation of VSV-G protein in a terminal export site (budding 
vesicle) associated with the ER network or accumulation in 
a  downstream post-ER,  pre-Golgi transport  intermediate, 
our preliminary analysis using immunoelectron microscopy 
strongly suggests the latter interpretation (W. E. Balch and 
M. G. Farquhar, unpublished data). The identification of  the 
intracellular compartment where  transport  is  blocked  by 
other trans dominant negative mutations is currently under 
investigation. 
Overexpression of rablanH yielded an identical biochemi- 
cal  phenotype  to  that  observed  for  rablbml.  Rabla  and 
rablb are 95 % identical, with the major differences being 
found in both conservative and nonconservative substitutions 
in the carboxyl-terminus (Zahraoui et al., 1989).  Given the 
ability  of mouse  rabla  to  substitute  for  YPTlp  in  yeast 
(Haubruck et al.,  1989),  our results suggest that rabla and 
rablb proteins may be functionally interchangeable in mam- 
malian cells. Redundancy in expression of  highly-related  iso- 
types is not unusual among members of the ras-superfamily 
of small GTP-binding proteins (Valencia  et al.,  1991). 
Biochemical and mutational analyses of rab-retated pro- 
teins found in the exocytic pathway of yeast (Schmitt et al., 
1988;  Bacon et al.,  1989;  Walworth et al.,  1989;  Baker et 
al., 1990; Kaiser and Schekman, 1990; Becker et al., 1991; 
Rexach and Schekman,  1991) supports our interpretation 
that rabl is essential for ER to Golgi transport. Specifically, 
YPTlI2n and SEC4133~ do not bind GTP and are dominant- 
lethal mutants (Salminen and Novick, 1987; Walworth et al., 
1989). Although the morphological and biochemical pheno- 
type of YPTlnl~ in the secretory pathway of yeast has not 
been examined, temperature-sensitive mutants of YPT1 ac- 
cumulate invertase and  carboxypeptidase  Y  in  the core- 
glycosylated pre-Golgi oligosaccharide forms, and accumu- 
late ER and pre-Golgi transport vesicles in vivo and in vitro 
(Schmitt et al., 1988; Segev et al., 1988; Bacon et al., 1989; 
Walworth et al., 1989; Baker et al., 1990; Kaiser and Schek- 
man,  1990;  Becker et al.,  1991). Likewise, SEC4133r leads 
to the accumulation of transport vesicles between the trans 
Golgi compartment and the cell surface (Walworth et al., 
1989). These data support our biochemical observations and 
morphological studies  suggesting that rablbnH  expression 
results in the accumulation of VSV-G protein in pre-Golgi 
compartments. However, unlike the reversal of the dominant 
lethal phenotype observed by overexpression of wild-type 
protein on the negative effects of SEC41221  and YPT11211 in 
yeast (Schmitt et al.,  1988; Walworth et al.,  1989),  overex- 
pression of rablb  wild type was unable to compete with 
rablb12tl. We suggest that rablb1211 may inhibit transport by 
an irreversible binding to an effector molecule(s) required 
for rablb function. 
The 116I (ras numbering) mutation in the NKXD domain 
of rab3a, rab5, rab6, and H-ras did not inhibit transport be- 
tween the ER and Golgi membranes, consistent with their 
lack of activity in the early compartments of the secretory 
pathway. Although rab6 has been localized to medial/trans 
compartments of the Golgi complex (Goud and McCaffrey, 
1991), overexpression of rab6126~ failed to inhibit processing 
of VSV-G to the complex sialic acid containing structure. 
Transport between the medial and trans Golgi compartments 
is likely to involve vesicular carriers (Rothman, 1987).  The 
inability of rab6~2~ to inhibit VSV-G transport suggests that 
rab6 does not regulate this step in the pathway.  The com- 
bined results strengthen the general model that specific rab 
proteins participate in unique molecular interactions which 
regulate the function of different membrane-bound compart- 
ments in the endocytic and exocytic pathways. The analogous 
rasnt~ substitution in different rab proteins will likely serve 
as a general and sensitive tool to define the role of uncharac- 
terized rab proteins in endomembrane function. 
In addition to the requirement for rabl, we have provided 
the first evidence that rab2 is essential for transport from the 
ER to the Golgi complex. Our data supports the observation 
that rab2 is localized to pre-Golgi tubular-vesicular elements 
believed to be involved in ER to Golgi transport (Chavrier 
et al.,  1990a;  Saraste and Kuismanen,  1984;  Saraste and 
Svensson,  1991; Schweizer et al.,  1988).  The evolutionary 
divergence of rab2 from rabl  (<40%  identity [Valencia  et 
al., 1991]) suggests that a distinct collection of upstream and 
downstream effector proteins regulating guanine nucleotide- 
binding, hydrolysis and/or membrane-association exists for 
the rab2 protein. To date, a tab2 homologue has not been de- 
tected in yeast. Whether the mammalian and yeast pathways 
differ in this respect is not known. 
Mutations in a  second domain involved in GTP-binding 
(GXXXXGKS/T) were examined (Table  1,  ras numbering 
10-17). The 17N substitution in ras is thought to result in for- 
marion of a GDP-complexed form (Feig and Cooper, 1988) 
due to the tight-binding of a ras specific GDS to this mutant 
protein. Because this protein is essential for normal ras func- 
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While the rablb22N was a potent inhibitor of transport, the 
identical substitution in rab2 had a markedly reduced effect. 
We would propose that GDP/GTP exchange is critical for 
regulation of  carrier vesicle function by rab 1. Although GDI 
and GDS proteins have now been identified for a number of 
rab and rab-related small GTP-binding proteins (reviewed in 
Takai et al., 1992) their role in transport and other cellular 
functions remains to be elucidated. 
We also examined the function of the highly conserved 
DTAGZEX domain (Table  1, ras numbering 5%63) which 
interacts with the phosphoryl group (Table 1). In the case of 
ras, this domain is critical for GTPase activity (Hall, 1990) 
and insures specificity to ras-GAP (Maruta et al.,  1991). 
RaSr~L mutants have impaired intrinsic and GAP-stimulated 
GTPase activities which favor formation of the active, GTP- 
complexed form and results in transformation (Der et al., 
1986).  Whereas rablb67L did not inhibit transport, rab2~L 
was  a  potent trans  dominant inhibitor of VSV-G protein 
transport. The failure of rablb67L to arrest transport mirrors 
the observation that a similar mutation in SEC4 (SEC479L) 
has no effect on vesicular transport from the trans Golgi to 
the cell surface in yeast (Walworth et al., 1989). In contrast, 
the inhibitory phenotype observed for rab2~L agrees with 
results reported for ras, suggesting that the inability to hydro- 
lyze GTP or enhanced GAP-binding contributes significantly 
to transport inhibition. Why rabl and rab2 differ in this re- 
spect is unknown. It may simply reflect differing roles of the 
GDP versus GTP bound forms in protein traffic. In this re- 
gard, the models that have been proposed to provide a gen- 
eral interpretation for rab protein function are likely to be 
oversimplified (Bourne, 1988). Clarification of these differ- 
ences will require purification of the relevant proteins and 
characterization of their activities in vitro in the context of 
vesicular transport. 
Mutations in the rabl and rab2 effector domains (Table 1, 
residues 32--40 [ras numbering]) were generated to disrupt 
the interaction with putative downstream effector molecules. 
Although effector domain mutations in YPT1 show a strong 
trans dominant phenotype (Becker et al., 1991) and a marked 
reduction in GTPase stimulation by YPT1-GAP  (Becker et 
al., 1991), identical mutations in rabl or rab2 only partially 
inhibited transport. Mouse rabla can substitute for YPTIp 
function in yeast only when the protein is strongly over- 
expressed (Haubruck et al.,  1989).  The combined results 
suggest that high levels of expression of rabla in null mutants 
lacking YPTI may be necessary to compensate for reduced 
affinity of rabla for yeast components rather than intrinsic 
stability. 
Mutations in the Carboxyl-terminal Domain 
Post-translational  modifications  of the  carboxyl-terminal 
cysteine residues of ras and related small GTP-binding pro- 
teins are critical for function in vivo (reviewed in Maltese, 
1990; Der and Cox, 1991). Due to the importance of preny- 
lation for function of ras and ras-related proteins, we antici- 
pated that the CC truncation would eliminate the trans domi- 
nant inhibition produced by rablb~2t[ expression.  Both the 
unprocessed (ACC) mutants of YPT~331 and SEC41331 in yeast 
(Schmitt et al., 1984; Walworth et al., 1989), or unprocessed 
oncogenic RAS/ras mutants in yeast and mammalian cells 
lack trans dominant function (Der and Cox, 1991). To our 
surprise the double mutant, rablb121~.acc remained a potent 
inhibitor of transport. A reasonable explanation is that lack 
of prenylation may lead to phenotypically distinct results for 
rab and ras-related proteins which reflect differences in their 
biochemical interactions. In the case of rablbmt,  the un- 
prenylated form may still participate in a subset of  biochemi- 
cal reactions characteristic of the wild-type protein. In sup- 
port of this interpretation, at least 50% of the unprocessed 
form  of rablb~2,.acc  sediments  with  membranes  (W.  E. 
Balch, unpublished observations). In this case, the rablb12u 
mutant may irreversibly bind a critical component(s) essen- 
tial for transport leading to inhibition. 
To gain insight into the role of  additional residues in the car- 
boxyl terminus for rabl function, we generated the rablbm~/ 
rab5 chimera. At least 35 amino acids of  the COOH-terminal 
tail of rab5 have recently been reported to be critical for 
localization of rab5 to the early endosome (Chavrier et al., 
1991). A rab2 chimera containing the carboxyl-terminus of 
tab5 is found in the early endosome (Chavrier et al., 1991). 
Because the rablb~2H/rab5 chimera had no inhibitory effect 
on transport, our results indicate that the carboxyl-terminal 
tail of  the rablb protein either contains essential sequence in- 
formation facilitating its interaction with the biochemical 
machinery governing transport, or that mislocalization (i.e., 
the endosomal pathway) efficiently segregates the mutant 
from proteins involved in ER to Golgi trafficking. 
Role of rab Proteins in Vesicular TraJficking Between 
the ER and Golgi Compartments 
The mutational analysis of rab protein function is consistent 
with a number of biochemical probes we have developed to 
explore rabl protein function in vitro. Recently we demon- 
strated that transport between the ER and the Golgi complex 
in vitro can be inhibited by a monoclonal antibody specific 
for rablb (Plutner et al., 1991). In the absence of  rablb, VSV-G 
protein fails to exit the ER suggesting that rabl  or rablb- 
associated proteins are essential for vesicle formation (Plut- 
ner et al., 1992). Upon initiation of  transport in vitro, VSV-G 
protein becomes rapidly transported to pre-Golgi intermedi- 
ates enriched in rabl (Plutner et al.,  1992;  Schwaninger et 
al., 1992). This rapid recruitment of rabl coupled to the ob- 
servation that the GDP-bound form of the SEC4 protein is 
required for membrane association CKabcenell et al., 1990; 
Saski et al., 1991) suggests that the rablb22N mutant may in- 
hibit transport by blocking the function of components in- 
volved in GDP/GTP exchange during an early step in vesicle 
formation. While the consequences of overexpression of the 
GDP-bound mutant form on cell morphology remain to be 
elucidated, an acti~tted form, such as the rablbm~ mutant 
may inhibit a later targeting or fusion step.  This interpreta- 
tion  is  supported  by the  observation that VSV-G  protein 
accumulates  in  punctate  vesicular  structures  which  are 
reminiscent of pre-Golgi intermediates (Saraste and Svens- 
son, 1991) in the presence of mutant protein in vivo, and in 
the presence of the rab3AL peptide in vitro (Schwaninger et 
al.,  1992).  Moreover, it is consistent with the observation 
that similar activating mutations in SEC4 (Walworth et al., 
1989) or YPT1 (Segev et al., 1988; Bacon et al., 1989; Baker 
et  al.,  1990;  Kaiser  and  Schekman,  1990;  Rexach  and 
Schekman, 1991) result in the accumulation of intermediate 
Tisdale et al. Rabl and Rab2 Regulation of ER to Golgi Transport  759 transport vesicles in viva and in vitro.  The role of rab2 in 
transport is unknown. However,  the observation  that endo- 
cytosis  involves at least two rab  proteins,  rab4  and rab5 
(Gorvel et al., 1991; van der Sluijs et al., 1991) suggests that 
multiple rab proteins may regulate sequential  or competing 
biochemical interactions between intraceUular compartments. 
Through examination of the biochemical and morpholog- 
ical consequences of expression of these and additional mu- 
tants on protein transport in viva and in vitro we hope to gain 
insight into the role of rabl and rab2 in ER to Golgi traffic. 
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